Effects of Resibufogenin and Cinobufagin on voltage-gated potassium channels in primary cultures of rat hippocampal neurons

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 1644-1653

  Hao, Shuang ^a   Bao, Yong Ming ^a   An, Li Jia ^a   Cheng, Wei ^a   Zhao, Rong Guo ^b   Bi, Jing ^a   Wang, He Shuang ^c   Sun, Chang Sen ^a   Liu, Ji Wen ^a   Jiang, Bo ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b Guoren Biological Technology Co Ltd   (China)

^c 255 Hospital of Chineses People's Liberation Army   (China)

Author keywords

Cinobufagin (CBG); Delayed rectifier potassium current (I K); Hippocampal neurons; Patch clamp; Resibufogenin (RBG); Transient potassium current (I A)

Indexed keywords

BUFOGENIN; CINOBUFAGIN; TETRODOTOXIN; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL KINETICS; CHANNEL GATING; CONTROLLED STUDY; DELAYED RECTIFIER POTASSIUM CURRENT; DRUG EFFICACY; DRUG MECHANISM; ELECTRIC POTENTIAL; HIPPOCAMPAL CA1 REGION; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PROBABILITY; RAT; TRANSIENT POTASSIUM CURRENT; WHOLE CELL;

AMPHIBIAN VENOMS; ANIMALS; BUFANOLIDES; CA1 REGION, HIPPOCAMPAL; CELLS, CULTURED; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

ANURA; RATTUS;

EID: 82655173943     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.07.001     Document Type: Article

References (40)

1. Adair B., Nunn R., Lewis S., Dukes L., Philipson L., Yeager M. Single particle image reconstruction of the human recombinant Kv2.1 channel. Biophys. J. 2008, 94:2106-2114.
2. + current in the learning mutant rutabaga. Learn Mem. 2002, 9:368-375.
3. Bick R.J., Poindexter B.J., Sweney R.R., Dasgupta A. Effects of Chansu, traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: Cardiotoxicity due to more than Na, K-ATPase blocking. Life Sci. 2002, 72:699-709.
4. + channels as targets of CNS drug development. Curr. Drug Targets 2004, 3:161-167.
5. Calavresi P., Pisani A., Mercuri N.B., Bemardi G. On the mechanisms underlying hupoxia-induced memebrane depolarization in striatal neurons. Brain 1995, 118:1814-1824.
6. + channels in dendrites of CA1 pyramidal neurons of rat hippocampus. J. Physiol. 2004, 559:187-203.
7. Chi X.X., Xu Z.C. Alterations of single potassium channel activity in CA1 pyramidal neurons after transient forebrain ischemia. Lett. Neurosci. 2001, 108:535-540.
8. Deng H.M., Yin S.T., Yan D., Tang M.L., Li C.C., Chen J.T., Wang M., Ruan D.Y. Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons. Toxicology 2008, 252:1-8.
9. Deng P., Pang Z.P., Zhang Y., Xu Z.C. Increase of delayed rectifier potassium currents in large aspiny neurons in the neostriatum following transient forebrain ischemia. Neuroscience 2005, 131:135-146.
10. Gribkoff V.K., Starrett J.E., Dworetsky S.I., Hewawasam P., Boissard C.G., Cook D.A., Frantz S.W., Heman K., Hibbard J.R., Huston K., Johnson G., Krishnan B.S., Kinney G.C., Lombardv L.A., Meanwell N.A., Molinoff P.B., Myers R.A., Moon S.L., Ortiz A., Pajor L., Pieschl R.L., Muson D.J., Signor L.J., Srinivas N., Taber M.T., Thalody G., Trojnacbi J.T., Wiener H., Yeleswaram K., Yeola S.W. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat. Med. 2001, 7:471-477.
11. Herrington J. Gating modifier peptides as probes of pancreatic β-cell physiology. Toxicon 2007, 49:231-238.
12. Houzen H., Kanno M. Thiamine and its derivatives inhibit delayed rectifier potassium channels of rat cultured cortical neurons. Neuropharmacology 1998, 37:313-322.
13. Jensen S.B., Strobaek D., Olesen S.P., Christophersen P. The Ca2+-activated K+ channel of intermediate conductance. a molecular target for novel treatments? Curr. Drug Targets 2001, 2:401-422.
14. + channel. Nature 2003, 423:33-41.
15. Kobrinsky E., Stevens L., Kazmi Y., Wray D., Soldatov N.M. Molecular rearrangements of the Kv2.1 potassium channel termini associated with voltage gating. J. Biol. Chem. 2006, 281:19233-19240.
16. Krylov V.N. Study of cardiotonic effect of venom of the Green Toad Bufo viridis. J. Evol. Biochem. Physiol. 2002, 38:223-228.
17. Leung Y.M., Kang Y.H., Gao X.D., Xia F.Z., Xie H.L., Sheu L., Tsuk S., Lotan I., Tsushima R.G., Gaisano H.Y. Syntaxin 1A binds to the cytoplasimic C terminus of Kv2.1 to regulate channel gating and trafficking. J. Biol. Chem. 2003, 278:17532-17538.
18. Liu Z.W., Ren G.G., Zhang T., Yang Z. Action potential changes associated with the inhibitory effects on voltage-gated sodium current of hippocampal CA1 neurons by silver nanopariticles. Toxicology 2009, 264:179-184.
19. Lvov A., Chikvashvili D., Michaelevski I., Lotan I. VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation. Pflugers Arch 2008, 456:1121-1136.
20. + channels in neuroendocrine isletβ-cell through an interaction with the channel N terminus. Mol. Endocrinlol. 2002, 16:2452-2461.
21. Makhina E.Z., Kim Y.J., Aizenman E., Levitan E.S. Novel neuroprotective K+ channel inhibitor indentified by high-throughput screening in yeast. Mol. Pharmacol. 2004, 65:214-219.
22. K, are encoded by Kv2α-subunits and regulate tonic firing in mammalian sympathetic neurons. J. Neurosci. 2002, 22:10094-10105.
23. + channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons. J. Neurosci. 1999, 19:1728-1735.
24. 2 terminus of Kv2.1 to channel activation. Am. J. Physiol. Cell Physiol. 1997, 273:1849-1858.
25. Pongs O. Voltage-gated potassium channels: from hyperexcitability to excitement. FEBS Lett. 1999, 452:31-35.
26. Rogawski M.A. Single voltage-dependent potassium channels in cultured rat hippocampal neurons. J. Neurophysiol. 1986, 56:481-493.
27. + channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 2000, 23:393-398.
28. + channels. Neuroscience 1988, 25:729-749.
29. Storm J.F. Potassium currents in hippocampal pyramidal cells. Prog. Brain Res. 1990, 83:161-187.
30. + channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 1995, 16:309-316.
31. 2+/calmodulin-dependent protein kinesis in human atrial myocytes. Circ. Res. 1999, 85:810-819.
32. Tian Y.T., Liu Z.W., Yang Y., Zhuo Y., Zhang T. Effect of alpha-cypermethrin and theta-cypermethrin on delayed rectifier potassium currents in rat hippocampal neurons. Neurotoxicology 2009, 30:269-273.
33. Vreugdenhil M., Faas G.C., Wadman W.J. Potassium currents in isolated CA1 neurons of the rat after kindling epileptogenesis. Neuroscience 1995, 66:805-813.
34. + channels as therapeutic drug targets. Pharmacol. Ther. 2002, 94:157-182.
35. Wray D. The roles of intracellular regions in the activation of voltage-dependent potassium channels. Eur. Biophys. J. 2004, 33:194-200.
36. Wu S.N., Lo Y.K., Chen H., Li H.F., Chiang H.T. Rutaecarpin-induced block of delayed rectifier K+ current in NG108-15 neuronal cells. Neuropharmacology 2001, 41:834-843.
37. Xie J.T., Wang H.S., Attele A.S., Yuan C.S. Effects of resibufogenin from toad venom on isolated Purkinje fibers. Am. J. Chin. Med. 2000, 28:187-196.
38. Xie J.Y., Dey L., Wu J.A., Lowell T.K., Yuan C.S. Cardiac toxicity of resibufogenin: electrophysiological evidence. Acta. Pharmacol. Sin. 2001, 22:289-297.
39. Yellen G. The voltage-gated potassium channels and their relatives. Nature 2002, 419:35-42.
40. Zhang H.X., Zhang W., Jin H.W., Wang X.L. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels. Mol. Brain Res 2004, 131:136-140.